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Volatilomic insight of head and 
neck cancer via the effects observed 
on saliva metabolites
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Head and neck cancer (HNC) is a heterogeneous malignant disease with distinct global distribution. 
Metabolic adaptations of HNC are significantly gaining clinical interests nowadays. Here, we 
investigated effects of HNC on differential expression of volatile metabolites in human saliva. We 
applied headspace solid phase microextraction coupled with gas chromatography-mass spectrometry 
analysis of saliva samples collected from 59 human subjects (HNC − 32, Control − 27). We identified 
and quantified 48 volatile organic metabolites (VOMs) and observed profound effects of HNC on these 
metabolites. These effects were VOM specific and significantly differed in the biologically comparable 
healthy controls. HNC induced changes in salivary VOM composition were well attributed to in vivo 
metabolic effects. A panel of 15 VOMs with variable importance in projection (VIP) score >1, false 
discovery rate (FDR) corrected p-value < 0.05 and log2 fold change (log2 FC) value of ≥0.58/≤−0.58 
were regarded as discriminatory metabolites of pathophysiological importance. Afterwards, receiver 
operator characteristic curve (ROC) projected certain VOMs viz., 1,4-dichlorobenzene, 1,2-decanediol, 
2,5-bis1,1-dimethylethylphenol and E-3-decen-2-ol with profound metabolic effects of HNC and 
highest class segregation potential. Moreover, metabolic pathways analysis portrayed several 
dysregulated pathways in HNC, which enhanced our basic understanding on salivary VOM changes. 
Our observations could redefine several known/already investigated systemic phenomenons (e.g. 
biochemical pathways). These findings will inspire further research in this direction and may open 
unconventional avenues for non-invasive monitoring of HNC and its therapy in the future.
Head and neck cancer (HNC) is a heterogeneous malignant condition characterised by tumours arising from 
the mucosal lining of oral cavity, facial sinus, salivary glands and pharynx1. HNC is one of the most common 
cancers across the globe and collectively contributed to 529,500 incidences and caused 292,300 fatalities in 20122. 
Especially in Indian subcontinent, tobacco and alcohol habits along with infections of human-pappilomavirus 
(HPV) and epstein-bar virus (EBV) are the major aetiology for high prevalence and malignancy of HNC3–5. 
Although, open biopsy is the only confirmatory diagnostic test used within a high-risk population, monitoring of 
HNC is rather compromised due to low availability of reliable clinical biomarkers6 and leads to the poor survival 
outcomes of HNC cases7–9. Due to its critical pathophysiology and ubiquitous manifestations, systemic/metabolic 
effects of HNC gained significant clinical importance during recent years.
Analysis of volatile metabolites is a steadily rising field of multidisciplinary metabolomics in relation to physi-
ological10–13, pathophysiological14–17 and therapeutic18–20 monitoring. In this perspective, non-invasive assessment 
of metabolic effects e.g. via salivary metabolites may enhance our conventional clinical understanding regarding 
HNC21. Saliva contains a range of different analytes including small organic metabolites and thereby, represents 
a resourceful biofluid for systemic information22,23. Moreover, simplicity of non-invasive sampling can facilitate 
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repeated measurements without causing additional discomfort to the patient24. Saliva being proximal fluid in 
HNC, reflects both physiological and pathophysiological state of the disease. Thus, saliva as a biometrics is often 
utilised in several omics approaches including genomics25,26, transcriptomics27,28, proteomics29,30 and metabolom-
ics31,32 for the discovery of HNC related biomarkers33. Eventually, there is a substantial gap of salivary volatilome 
use in clinical practices to assess the disease progression and monitor pathophysiology. Thus, analysing altered 
salivary volatilome in HNC patients is a practical approach to understand disease induced metabolic adaptations 
via identifying changes in concentrations of volatile organic metabolites (VOMs). Previously, we have evaluated 
the urinary volatile profiles from HNC cases using headspace solid phase microextraction (HS-SPME) approach 
coupled with gas-chromatography mass-spectrometry (GC-MS)34.
In the present study, we have demonstrated for the first time that HNC pathology driven changes in salivary 
volatilomic compositions can be efficiently extracted by HS-SPME and then quantified by GC-MS analysis. Here, 
we analysed volatile compositions of saliva in a cohort of 59 subjects (32 HNC patients and 27 controls) through 
our optimised HS-SPME GC/MS analytical setup. In this work, we aim to address the effects of HNC on saliva 
VOMs and if these effects were related to metabolic changes induced by HNC pathophysiology.
Results
Salivary volatilome identification by GC-MS. A total of 57 VOMs with ≥75% match with NIST library 
was identified in a cohort of 59 subjects, out of which, only 48 VOMs were finally considered for further statistical 
analysis (Supplementary Table S1). Those 9 VOMs were excluded as they were missing from >50% of samples. 
Representative chromatograms of HNC and control salivary VOMs are depicted in Fig. 1a. The identified VOMs 
belong to several chemical classes including aldehydes, ketones, alcohols, alkanes, organic acids, benzene deriva-
tives and phenolic compound etc. As expected, some of the VOMs were differentially expressed in HNC as com-
pared to controls, as shown in Fig. 1b. Furthermore, we have submitted our study to the MetaboLights database 
which can be accessed by ID MTBLS760.
Identification of HNC specific salivary volatilome signature by multivariate statistical analy-
sis. Overall, 27 VOMs of interest were selected via univariate statistical analysis such as wilcoxon rank sum 
test (p ≤ 0.05) along with their respective log2 FC values (≥0.58/≤−0.57), which are summarised in supplemen-
tary Table S2. Prominent group separation was observed in the principal component analysis (PCA) score plot 
revealing inherent concentration differences in salivary VOMs affected by HNC (Fig. 2a). Further enhanced 
group separation was achieved in orthogonal projections to latent structures discriminant analysis (OPLS-DA) 
model (Fig. 2b). Since the number of independent variables are higher than the sample size, statistical models 
such as OPLS-DA tends to over fit the data and give biased output or Voodoo correlations. Therefore, permu-
tation validation (200 permutations) of OPLS-DA models was carried out to support its feasibility for our pilot 
approach (Fig. 2c). The permutation validation of OPLS-DA model yielded R2 and Q2 values of 0.941 and 0.867, 
respectively, indicating that the original model has high goodness of fit and good class prediction ability com-
pared to permutated models and thus can be considered as a preliminary and realistic pilot model. VIP (variables 
important in projection) is regarded as criteria for selecting and ranking VOMs as per their contribution to class 
segregation in OPLS-DA score plot (Supplementary Fig. S1). Accordingly, a total of 15 VOMs were selected based 
on VIP > 1, FDR corrected p-value < 0.05, log2 FC value of ≥0.58/≤−0.58 and considered as most important 
differentially expressed metabolites responsible for class separation (Table 1). Some of the VOMs were validated 
by matching their fragmentation pattern as well as Kovats index with respective pure standard (Supplementary 
Table S3).
The heat map in Fig. 3a represents participant cohort related Hierarchical Cluster Analysis (HCA) cluster-
ing patterns. Each column in heat map indicates the metabolic pattern of individual subject in HNC and con-
trol cohort. Those colour patterns semi-quantitatively indicate varying alterations in salivary VOMs. A distinct 
clustering pattern associated with each study group was visible, indicating HNC specific intrinsic concentration 
differences in the VOMs. A dendrogram analysis had further segregated study subjects into their respective class 
and complemented initial HCA findings (Fig. 3b).
Receiver operator characteristic (ROC) curve analysis of salivary VOMs. Among all the metabo-
lites, we observed four VOMs with highest specificity and sensitivity for class segregation between study cohorts. 
These are 1,4-dichlorobenzene (AUC 0.998), 1,2-decanediol (AUC 0.939), 2,5-bis1,1-dimethylethylphenol 
(AUC 0.913) and E-3-decen-2-ol (AUC 0.889). Specificity, sensitivity and respective log2 FC with FDR corrected 
p-values of identified VOMs are depicted in Fig. 4 and Table 2.
Identification of HNC altered metabolic pathways. As indicated in Fig. 5, the metabolic pathways 
which are excessively active in HNC are glycolysis or gluconeogenesis, pyruvate metabolism, sulphur metabo-
lism, selenoamino acid metabolism, taurine and hypotaurine metabolism, glycerolipid metabolism and tyrosine 
metabolism. We observed that nicotinate and nicotinamide metabolism was down regulated (further details are 
available in the Supplementary Table S4).
Discussion
We observed profound effects of HNC on the volatile metabolite composition of human saliva. The VOMs iden-
tified in the saliva of study cohort belong to various chemical classes including organic acids, alcohols, phenolics, 
benzene derivatives and hydrocarbon etc. and those effects were also substance specific. Observed changes in 
VOM concentrations were significantly different in the biologically comparable but healthy control group. HNC 
induced changes were well attributed to in vivo metabolic effects induced by HNC pathophysiology.
Interestingly, metabolically demanding environments such as hypoxia and nutrient depletion induces sig-
nificant metabolic reprogramming in cancer cells including enhanced glycolysis, lipogenesis and reduced 
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dependence on oxidative phosphorylation, which is necessary to maintain a high rate of proliferation and exhibit 
malignant characteristics, such as altered cellular bioenergetics and metastatic behaviour35,36. It is important 
to note that the acetic acid and ethyl acetate were up-regulated in HNC subjects. It is well known that acetate 
serves as an alternative nutrient for cancer cells to support energy- and biomass production under hypoxia37,38. 
Moreover, acetate induces fatty acid synthesis as an immediate metabolic precursor and also functions as an 
epigenetic metabolite to promote cancer cell survival39,40. In fact, the enzyme nucleocytosol-localised acetyl CoA 
synthetase (ACSS2) involved in fatty acid biosynthesis is implicated as crucial enzyme for growth and survival of 
breast and prostate cancer cells cultured in hypoxic and low nutrient environment. This makes it an a attractive 
target for therapeutic studies41.
Genetic aberrations in malignant cells promote elevated oxidative stress, including high reactive oxygen 
species (ROS) production, which contributes significantly to lipid peroxidation of poly unsaturated fatty acids 
(PUFAs) and generates compounds such as 2,3,3-trimethylpentane and 1,2,3,4-tetrachlorobutane42,43. One 
of these alkanes, 2,3,3-trimethylpentane was found upregulated in the HNC patients compared to controls, 
which indicates a possible increase in ROS-mediated lipid peroxidation in HNC. In contrast, the other alkane, 
1,2,3,4-tetrachlorobutane was found significantly reduced in HNC patients, which was most probably due to the 
conversion of this alkane to alcohol 1-chloro-2-butanol. Consequently, these alcohols were found in elevated con-
centrations. Such conversion can be mediated by enzymes like cytochrome P450, which are often induced during 
Figure 1. (a) Representative chromatogram of control and HNC subject, (b) Representative merged 
chromatogram depicting differential regulation of acetic acid and 1, 2-decanediol in HNC and control subject.
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Figure 2. Analysis of altered salivary volatomic signatures by multivariate statistical tools. (a) Principal 
component analysis (PCA) of control and HNC subjects, (b) Orthogonal projections to latent structures 
discriminant analysis (OPLS-DA) of control and HNC subjects, (c) Permutation validation of OPLS-DA model. 
A total of 200 permutations were carried out to validate the model.
Sr. No. Compound Name HMDB ID VIP score p-value FDR Log2 FC
1 1,4-Dichlorobenzene HMDB0041971 1.95 5.77E-11 2.77E-09 −4.46
2 1,2-Decanediol — 1.76 7.48E-09 1.79E-07 −2.60
3 2,5-Bis1,1-dimethylethylphenol — 1.59 8.32E-08 1.33E-06 −4.77
4 Propanoic acid, ethyl ester HMDB0030058 1.45 1.06E-06 1.02E-05 3.38
5 E-3-Decen-2-ol — 1.42 4.28E-07 5.13E-06 −2.34
6 Acetic acid HMDB0000042 1.28 3.55E-06 2.84E-05 3.67
7 Propanoic acid HMDB0000237 1.26 1.71E-05 0.000117 −1.36
8 Ethyl Acetate HMDB0031217 1.21 0.000109 0.000524 1.86
9 2,4-Dimethyl-1-heptene — 1.17 4.78E-05 0.000277 2.10
10 1-Chloro-2-propanol — 1.15 0.002764 0.006318 1.74
11 1-Chloro-2-butanol — 1.11 0.005423 0.011318 1.08
12 2-Propenoic acid HMDB0031647 1.03 0.000135 0.000587 −0.81
13 2,3,3-Trimethylpentane — 1.015 0.000333 0.001229 3.17
14 Ethanol — 1.013 0.000674 0.002245 −1.00
15 1,2,3,4-Tetrachlorobutane HMDB0000108 1.012 0.001216 0.003242 −0.81
Table 1. The important discriminatory salivary VOMs selected by univariate and multivariate statistical 
analysis. Abbreviations: FDR- false discovery rate, VIP- variable importance in projection.
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malignant conditions and hydroxylate alkanes generated during lipid peroxidation of PUFA44. Similarly, another 
alcohol “1-chloro-2-propanol” was also found at elevated concentration in presence of HNC.
Propanoic acid, a short chain fatty (SCF) acid mainly produced by anaerobic gut microbiota, showed 
down-regulation, while its ester derivative, ethyl ester propanoic acid (ethyl propionate), is significantly 
up-regulated in HNC cases. Overall, this reflects the up-regulation of propanoate under HNC. Propanoic acid is 
associated with a significant immunoregulatory activity and enhanced tissue sensitivity to insulin which makes it 
beneficial in the context of obesity and diabetes type 2. However, the mechanisms by which propanoate exert its 
effect on immunity and physiology in malignant conditions is still largely unknown45,46.
The metabolic pathway analysis revealed several up-regulated pathways in HNC subjects, including glycolysis 
or gluconeogenesis and pyruvate metabolism, which are in agreement with the higher aerobic glycolysis (i.e. 
Warburg effect) observed in cancer cells47. Similarly, it is well-known that hypotaurine is involved in the pro-
tection against oxidative stress and ROS generation, therefore, it is not surprising that taurine and hypotaurine 
metabolism is upregulated in HNC cases48. Finally, the upregulation of the Glycerolipid metabolic pathway in the 
HNC patients is also in accordance with a recent study showing that several genes in the glycerolipid metabolism 
are upregulated during tumorigenesis and metastasis49.
Taken together, our results have projected an unconventional understanding of HNC pathophysiology driven 
changes in cellular biochemistry and metabolic homeostasis. Once translated through rational clinical reasoning, 
this knowledge can substantially contribute to the understanding of several crucial aspects associated with HNC. 
Moreover, our observations could be accounted for several known/already investigated systemic phenomena 
Figure 3. (a) Hierarchical clustering analysis of salivary volatilome shown as heat map and (b) dendrogram 
analysis of volatilomic data of HNC study subjects. The distance was calculated by ward’s method and sorted by 
size.
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(e.g. biochemical pathways). Our findings are novel and significantly important to warrant further investigations 
of disease driven metabolic effects through non-invasive follow-up of saliva and similar matrixes in the future. 
As there are insufficient references for retrospective frame in omics, prospective measurements and follow-up 
are mandatory to perceive a reasonable and rational clinical interpretation of differentially expressed VOMs as 
disease specific biomarkers.
Conclusions
Our findings have provided a volatilomic insight into the salivary metabolite alterations under HNC. Further, 
clues from metabolic analysis indicated that short chain fatty acids might have significant role in HNC metabo-
lism and bioenergetics. Though, the role of acetate in cancer cell metabolism is well scrutinised, the function of 
propanoate remains to be investigated further. These results therefore have contributed new basic and clinical 
knowledge in the field of HNC metabolomics and should foster multi-location clinical studies with larger cohorts 
to validate such findings. As VOMs inherits potential to be integrated in sensor-based Point of Care (PoC) appli-
cations, HNC prognosis and follow-up especially areas with limited modern healthcare access could be benefited 
in future.
Materials and Methods
All experiments were performed in accordance to the Declaration of Helsinki (DoH) guidelines. The study was 
approved by the ethics committee of Armed Forces Medical College (AFMC) Pune and National Centre for Cell 
Science (NCCS), Pune. All the subjects voluntarily participated in the study after being informed about the inves-
tigation undertaken and written informed consent was obtained from them.
Subject selection. Malignant Disease Treatment Centre (MDTC) of Military Hospital-Cardio Thoracic 
Centre (MH-CTC), Armed Forces Medical College (AFMC), Pune, India contributed towards collection of HNC 
saliva samples (n = 32). Control saliva samples (n = 27) were obtained at health check-up camps organised by 
the same hospital. Subject inclusion criteria for HNC were minimum 18 years old patient with histopathological 
Figure 4. Receiver operator characteristic curve analysis of (a) 1,4-dichlorobenzene; (b) 1,2-decanediol; (c) 
2,5-bis1,1-dimethylethyl and (d) E-3-decen-2-ol.
Compound HMDB AUC Sensitivity Specificity p-value FDR Log2 FC
1,4-Dichlorobenzene HMDB0041971 0.998 1 1 5.77E-11 2.77E-09 −4.46
1,2-Decanediol — 0.939 1 0.8 7.48E-09 1.79E-07 −2.60
2,5-Bis1,1-dimethylethyl- phenol — 0.913 0.9 0.8 8.32E-08 1.33E-06 −4.77
E-3-Decen-2-ol — 0.889 0.8 0.8 4.28E-07 5.13E-06 −2.34
Table 2. The salivary VOMs with highest specificity and sensitivity to discriminate HNC from control subjects. 
Abbreviations: AUC- area under curve, FDR- false discovery rate.
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confirmation of malignant lesion without any anticancer therapeutic intervention. Similarly, age and gender 
matched control subjects without hypertension, diabetes or any medication during last 3 months were recruited 
for this study. The clinical attributes of the study cohort are summarized in Supplementary Table S5.
Sample collection. Saliva sampling was performed as recently reported50. Briefly, the saliva samples were 
collected during hospitalisation between 9.00 am to 12.00 at noon. Eating and drinking was not allowed at least 
2 hours prior to sample collection. Each subject thoroughly rinsed their mouth with water and approximately 
2 mL un-stimulated saliva was collected in 10 mL sterilised glass vial with screw cap and immediately placed on 
ice. All the samples were transported to the laboratory within 1 hour of sample collection and stored at −80 °C 
until further processing.
Sample processing. Headspace - Solid Phase Microextraction (HS-SPME) approach was used for the 
extraction of the salivary VOMs. Detailed methodology for VOCs extraction from saliva was followed as per 
recently reported by Cavaco et al.50. Accordingly, samples were ice thawed and 1 mL saliva was transferred to 
a 4 mL headspace glass vial (Thermo Fisher, USA), acidified with 125 µL of 5 M HCL (Merck, Germany) and 
added 100 mg of NaCl (Merck, Germany). A magnetic stirring bar (0.5 × 0.1 mm) was also added to the vial that 
was closed with a Teflon (PTFE) septum screw cap. To concentrate the VOMs, a carboxen/polydimethylsiloxane 
(CAR/PDMS, 75 μm, Supelco, USA) SPME fibre was exposed to the headspace of the vial through the PTFE septa 
and incubated at 38 ± 1 °C for 45 min with continuous stirring at 800 rpm. After incubation, CAR/PDMS fibre 
was desorbed in the back-inlet port of the GC (250 °C) for 6 min. The CAR/PDMS fibre was preconditioned at 
260 °C for 20 min to eliminate any residual VOMs from previous samples.
GC-MS parameters and data pre-processing. Headspace extracted VOMs were analysed on BP-20 
(SGE, Germany) fused silica capillary column (60 m × 0.25 mm × 0.25 µm) fitted to Agilent 7890B gas chroma-
tograph (Palo Alto, USA) equipped with Agilent 5977 A quadrupole inert mass selective detector. The oven tem-
perature programme was constituted as follows: initial temperature 45 °C held for 5 min, then increased to 150 °C 
with increment of 2 °C min−1 and followed by 10 min hold, then temperature was ramped up to 220 °C at the 
rate of 15 °C min−1 and further held for 15 min, with total run time of 87 min. Helium (99.999% purity, Prama 
Enterprises, India) was used as carrier gas at 1 mL min−1. The injections in splitless mode were performed with 
the back-inlet port maintained at 250 °C. The temperatures of transfer line, ionization source and quadrupole 
were maintained at 250 °C, 230 °C and 150 °C, respectively. After 5 min of solvent delay, data acquisitions were 
carried out in full scan mode in the range of 30 to 300 m/z and mass spectra were recorded at 70 eV. All the 
samples were acquired in duplicate and metabolites were identified by manual scrutiny of chromatograms by 
Chemstation software (Palo Alto, USA) equipped with NIST 11 library and by comparing mass spectra of pure 
standards when available. We have also carried out quality control samples (after every 10 samples) and blanks 
(after every 3 samples) to check the run to run variation as well as to detect any residual overhang of the previous 
samples. Metabolites were selected for further analysis based on match score of ≥75%. Metabolites missing from 
>50% of samples were removed from the final analysis.
Figure 5. (a) Metabolic pathway analysis of salivary VOMs of HNC and control subjects. 1 – propanoate 
metabolism, 2 - glycolysis or gluconeogenesis, 3 - Pyruvate metabolism, 4–sulphur metabolism, 5 – 
selenoamino acid metabolism, 6 - taurine and hypotaurine metabolism, 7 - Nicotinate and nicotinamide 
metabolism, 8 - synthesis and degradation of ketone bodies, (b) Propanoate metabolic pathway. C00163 
represents propanoic acid and C00207 represents acetone.
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Statistical Analysis. In order to understand the influence of HCN on salivary volatiles, GC-MS derived 
peak area of each VOMs of interest were computed and treated by univariate and multivariate statistical meth-
ods. Features with <50% missing values were imputed by half of the minimum positive value in the data. The 
data was quantile normalised, transformed by log transformation and scaled by range scaling (Supplementary 
Fig. S2). Normalisation was carried out to remove the bulk differences among the samples in order to reduce the 
complexity of data and to make distribution of variables uniform across the samples so that the features can be 
more comparable.
At first, univariate statistical analysis i.e. wilcoxon rank sum test (a non-parametric t-test) was carried out 
to investigate differences in the concentrations of salivary VOMs in the subjects recruited. A FDR corrected 
p-value < 0.05 was used as criteria to select metabolites which are significantly altered in HNC subjects. Moreover, 
log2 FC of the identified VOMs was also carried out by calculating log2 transformation ratio of the mean metab-
olite abundance in HNC subjects relative to the control subjects. A log2 FC of≥ 0.58 is considered as a significant 
upregulation of the metabolite in HNC subjects while values ≤ −0.58 represents down regulation of metabolites. 
Data normalization and univariate statistical analysis as well as HCA, ROC curve and metabolic pathway analyses 
were carried out by Metaboanalyst 3.051. Furthermore, to realize HNC affected salivary volatiles, multivariate sta-
tistical tools such as PCA and OPLS-DA were employed by using SIMCA 14.0 (Umetrics, Umea Sweden). At first, 
the PCA (an unsupervised multivariate statistical approach) was used to generate overview of data distribution 
across samples and detect possible outliers. Afterwards, a supervised multivariate statistical tool i.e. OPLS-DA 
was applied to enhance group separation. Moreover, the PCA was also plotted using the QC samples to ensure the 
data quality was not compromised (Supplementary Fig. S3).
HCA was performed using the concentration profile of each VOM to see clustering patterns associated with 
the participants. A heat map was generated using Minkowski distance measure and average algorithm. For den-
drogram analysis, distance was measured by Ward algorithm and sorted by size. ROC curve analysis of salivary 
VOMs was performed to identify the varying metabolic effects on measured VOMs in diseased and control sam-
ples using MS peak areas.
Metabolic pathways analysis. The salivary volatiolomic profiles of study subjects were used to get the 
overview of significantly dysregulated metabolic pathways in HNC with the help of MetPA tool of Metaboanalyst 
3.0 web application.
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